GROWTH-FACTORS AND DIABETIC COMPLICATIONS

[1] Young FG, Permanent diabetes produced by pituitary (anterior lobe) injections, Lancet, 2, pp. 372-374, (1937)

[2] Campbell J., Davidson IWF, Lei HP, The production of permanent diabetes by highly purified growth hormone, Endocrinology, 46, pp. 588-590, (1950)

[3] Yde H., Abnormal growth hormone response to ingestion of glucose in juvenile diabetics, Acta Med Scand, 186, pp. 499-504, (1969)

[4] Hansen, Johansen K., Diurnal pattern of blood glucose, serum FFA, insulin, glucagon and growth hormone in normals and juvenile diabetics, Diabetologia, 6, pp. 27-33, (1970)

[5] Lundbaek K., Christensen NJ, Jensen VA, Et al., Diabetes, diabetic angiopathy and growth hormone (hypothesis), Lancet, 2, pp. 131-133, (1970)

[6] Yde H., The growth hormone dependent sulphation factor in serum from patients with various types of diabetes, Acta Med Scand, 186, pp. 293-297, (1969)

[7] Press M., Tamborlane WV, Sherwin S., Importance of raised growth hormone levels in mediating the metabolic derangement of diabetes, N Engl J Med, 310, pp. 810-815, (1984)

[8] Bratusch-Marrain PR, Smith D., DeFronzo RA, The effect of growth hormone on glucose metabolism and insulin secretion in man, The Journal of Clinical Endocrinology & Metabolism, 55, pp. 973-982, (1982)

[9] Gerich JE, Lorenzi M., Bier DM, Et al., Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin, J Clin Invest, 57, pp. 875-884, (1976)

[10] Bolli GB, DeFeo P., DeCosmo S., Et al., Demonstration of the dawn phenomenon in normal human volunteers, Diabetes, 33, pp. 1150-1153, (1984)

[1] Young FG, Permanent diabetes produced by pituitary (anterior lobe) injections, Lancet, 2, pp. 372-374, (1937)

[2] Campbell J., Davidson IWF, Lei HP, The production of permanent diabetes by highly purified growth hormone, Endocrinology, 46, pp. 588-590, (1950)

[3] Yde H., Abnormal growth hormone response to ingestion of glucose in juvenile diabetics, Acta Med Scand, 186, pp. 499-504, (1969)

[4] Hansen, Johansen K., Diurnal pattern of blood glucose, serum FFA, insulin, glucagon and growth hormone in normals and juvenile diabetics, Diabetologia, 6, pp. 27-33, (1970)

[5] Lundbaek K., Christensen NJ, Jensen VA, Et al., Diabetes, diabetic angiopathy and growth hormone (hypothesis), Lancet, 2, pp. 131-133, (1970)

[6] Yde H., The growth hormone dependent sulphation factor in serum from patients with various types of diabetes, Acta Med Scand, 186, pp. 293-297, (1969)

[7] Press M., Tamborlane WV, Sherwin S., Importance of raised growth hormone levels in mediating the metabolic derangement of diabetes, N Engl J Med, 310, pp. 810-815, (1984)

[8] Bratusch-Marrain PR, Smith D., DeFronzo RA, The effect of growth hormone on glucose metabolism and insulin secretion in man, The Journal of Clinical Endocrinology & Metabolism, 55, pp. 973-982, (1982)

[9] Gerich JE, Lorenzi M., Bier DM, Et al., Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin, J Clin Invest, 57, pp. 875-884, (1976)

[10] Bolli GB, DeFeo P., DeCosmo S., Et al., Demonstration of the dawn phenomenon in normal human volunteers, Diabetes, 33, pp. 1150-1153, (1984)